Advent Pharmaceuticals, L.L.C. (AP) is a Limited Liability Company with offices in Milford, MI, and in Shanghai, China. The principals of AP represent a combined experience of over 40 years in the pharmaceutical and devices industry internationally.
John R. Choate is CEO and has 26 years of experience in the domestic and international medical device and pharmaceutical industries. In 1988 Mr. Choate founded Myco Industries; an ophthalmic device manufacturer based in Michigan. In 2000 Myco formed a strategic alliance with Shanghai Taisheng Science and Technology Development Co. Ltd in Shanghai, China to seek approval of drugs and devices by the SFDA in China. AP was incorporated in 2009.
Feng Li, is a Senior Vice President and has a Ph.D in pathology and an M.D from Shanghai Medical University, Shanghai, China. Mr. Li has more than eight years industrial field application support experience, more than five years biomedical research experience in Protein Chemistry, Cell biology and Molecular biology, expertise in computational analysis and interpretation of genomic and proteomic data utilizing bioinformatics tools and is Bilingual speaking fluent Mandarin (Chinese) and English.